主要成就
代表论文：
[1] Investigation of reduction process and related impurities in ezetimibe. Su Jiangtao etc. Journal of Pharmaceutical and Biomedical Analysis. 2015.107: 355-363.
[2]Isolation, identification and structure elucidation of two novel process-related impurities of retigabine. Su Jiangtao. Journal of Pharmaceutical and Biomedical Analysis. 2014.99:22-27.
[3] Isolation, identification and characterization of novel process-related impurities in flupirtine maleate. Su Jiangtao. Journal of Pharmaceutical and Biomedical Analysis. 2014.90:27-34.
[4] Practical, efficient synthesis of N-mono-substituted β-amino tertiary thiols via reductive ring-opening of 3-thiazolines. Su Jiangtao. Res. Chem. Intermed. 2013. 39:767-770.
[5] Identification, characterization and HPLC quantification for process-related impurities in abiraterone acetate bulk drug. Journal of Chromatographic Science. 2018. 5:1-10.
[6] HPLC法测定(S)-2-氨基丁酰胺对映异构体 苏江涛.分析试验室.2015,34（10），1200-1203.
[7] 新族亚硝基硫醇分子的设计合成及NO释放稳定性研究.苏江涛.分子科学学报.2016(32),
[8] 一种S-亚硝基二硫醇的合成及特性分析. 化学试剂. 2017.4(1):357-360.
[9] 用紫外导数风光光度法测定复方替米沙坦氨氯地平片的含量. 苏江涛.药学实践杂志. 2017. 2: 150-153.
[10] 一种光照诱导原位产生过氧亚硝酸根的新方法.苏江涛.化学试剂. 2017.1:80-83.
[11] 细辛脑的临床前毒性研究进展.苏江涛.毒理学杂志.2019.2:161-165.
[12] A concise synthesis of the angular dihydrofuroquinoline alkaloids via cyclopropane opening in the presence of polyphosphoric acid. Jiangtao Su, Juan Xiong, Shucai Liang, Guofu Qiu, Xichun Feng, Hanbing Teng, Lamei Wu, Xianming Hu *. Synthetic Communication. 2006.36:1-6.
[13] Facile Synthesis of β-Azidocyclopropanecarboxylate by MIRC Reaction. Jiangtao Su, Guofu Qiu, Shucai Liang, Xianming Hu. Synthetic Communication. 2005.35:1427-1433.
申请专利：
[1]发明专利：一种盐酸苯达莫司汀中间体的制备方法 授权公告号CN102558069B
[2]发明专利：醋酸阿比特龙二聚体化合物的制备及检测方法 授权公告号CN102816199 A
[3]发明专利：一种卡培他滨制备工艺中的中间体的制备方法 授权公告号CN103159813A
